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Abstract
Enamel matrix derivative (EMD), a porcine extract harvested from developing porcine teeth, has been shown to promote
formation of new cementum, periodontal ligament and alveolar bone. Despite its widespread use, an incredibly large
variability among in vitro studies has been observed. The aim of the present study was to determine the influence of EMD
on cells at different maturation stages of osteoblast differentiation by testing 6 cell types to determine if cell phenotype
plays a role in cell behaviour following treatment with EMD. Six cell types including MC3T3-E1 pre-osteoblasts, rat calvarial
osteoblasts, human periodontal ligament (PDL) cells, ROS cells, MG63 cells and human alveolar osteoblasts were cultured in
the presence or absence of EMD and proliferation rates were quantified by an MTS assay. Gene expression of
collagen1(COL1), alkaline phosphate(ALP) and osteocalcin(OC) were investigated by real-time PCR. While EMD significantly
increased cell proliferation of all cell types, its effect on osteoblast differentiation was more variable. EMD significantly up-
regulated gene expression of COL1, ALP and OC in cells early in their differentiation process when compared to osteoblasts
at later stages of maturation. Furthermore, the effect of cell passaging of primary human PDL cells (passage 2 to 15) was
tested in response to treatment with EMD. EMD significantly increased cell proliferation and differentiation of cells at
passages 2–5 however had completely lost their ability to respond to EMD by passages 10+. The results from the present
study suggest that cell stimulation with EMD has a more pronounced effect on cells earlier in their differentiation process
and may partially explain why treatment with EMD primarily favors regeneration of periodontal defects (where the
periodontal ligament contains a higher number of undifferentiated progenitor cells) over regeneration of pure alveolar
bone defects containing no periodontal ligament and a more limited number of osteoprogenitor cells.
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Introduction
The goal of regenerative periodontal therapy is the reconstitu-
tion of the lost periodontal structures (i.e. the new formation of
root cementum, periodontal ligament and alveolar bone) [1–3].
Results from preclinical and clinical research in the last decade
have provided evidence for the biologic rationale and clinical
applications of an enamel matrix derivative in periodontal wound
healing/regeneration [4]. However, in light of the known
functions of enamel matrix proteins (EMPs) during enamel
formation (amelogenesis) [5,6], a function in periodontal regener-
ation may seem controversial. In this context, it is important to
know that EMPs, besides having roles in regulating the initiation
and growth of hydroxyapatite crystals during the formation of
enamel, are involved in the cell differentiation processes of many
cell types [7–14]. Of particular interest are observations suggesting
that specific amelogenin splice products may function as potential
epithelial-mesenchymal signaling molecules during tooth develop-
ment [15–18].
Initial in vitro studies demonstrated that PDL cells grown on
dentin slices were unable to form cementum without specific
EMPs demonstrating the critical importance of EMPs during
cementogenesis [19]. These proteins have since been formulated
into an enamel matrix derivative (EMD) for clinical application
(Emdogain, Institut Straumann AG, Basel, Switzerland). The
major components of EMD are amelogenins a family of
hydrophobic proteins derived from different splice variants and
controlled by post-secretory processing from a single gene that
account for more than 95% of the total protein content [20].
These proteins self-assemble into supramolecular aggregates that
form an insoluble extracellular matrix that function to control the
ultrastructural organization of the developing enamel crystallites
[20]. Other proteins found in the enamel matrix include enamelin,
ameloblastin (also called amelin or sheathlin), amelotin, apin, and
various proteinases [5,6]. Although the role of EMPs in cell
differentiation has been extensively investigated, large variability
of effectiveness exists amongst in vitro and clinical studies. While a
large number of studies have demonstrated that EMD promotes
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both cell growth (proliferation) and differentiation [21–34], others
have failed to show any additional benefit towards differentiation
[35–38] and a small number have demonstrated an inhibitory
effect on either cell proliferation or differentiation [39–41].
One important factor that has not been investigated is the
influence of cell type on osteoblast behaviour in response to
treatment with EMD. Since a large number of different primary
and cell-line derived osteoblasts have been utilised for in vitro
studies (MC3T3E-1, rat calvarial osteoblasts, ROS osteoblasts,
MG63 osteoblast cell line, primary human osteobasts and PDL
cells), it is plausible that some of the observed variability is caused
by the differentiation stage at which osteoblast were tested. Since
EMPs are embryologically used to differentiate cells early in their
differentiation process, it is logical to hypothesize that EMD would
also have a more pronounced effect on cells early in their
differentiated process and that culture conditions may generate
variable in vitro results based on this phenomenon.
Therefore, the aims of the present study were 1) to test the
effects of EMD on 6 different osteoblast cell types (both primary
and cell-lines) at different stages in osteoblast differentiation; 2) To
test the effect of cell passaging on the responsiveness of EMD by
comparing the effects of EMD on primary human PDL cells
having been passaged between 2 and 15 times; 3) To test the
effects of EMD on MC3T3-E1 pre-osteoblasts that have gradually
been differentiated down the osteoblast phenotype.
Methods
Coating with EMD
EMD was prepared according to Institut Straumann AG
standard operating protocols. 30 mg of EMD was dissolved in
3 ml of 4uC sterile 0.1% acetic acid. For experiments, stock EMD
was diluted 100X in 0.1 M carbonate buffer at 4uC giving a
working solution of 100 mg/ml. 1 ml of EMD solution was poured
onto 100 mg of tissue culture plastic in 24 well culture dishes and
incubated overnight at 4uC. Following incubation, samples were
rinsed with 1 ml phosphate buffered saline (PBS, pH 7.4,
Catalogue #, 10010–023, Gibco) twice at 4uC.
Osteoblast and PDL Cell Isolation
Primary human osteoblasts were obtained from an explant
model as previously described [42]. PDL cells were obtained from
the middle third portion of teeth extracted for orthodontic reasons
as previously described [42]. RCOs were harvested by collagenase
digestion as previously described [33]. Briefly RCOs were
obtained from newborn rat calvariae following decapitation.
Frontal, parietal and occipital bones were dissected and rinsed in
a-MEM (Gibco, Grand Island, NY, USA). Minced tissue was
digested twice for 15 min each in a mixture of collagenase/trypsin
(3:1; both purchased from Sigma-Aldrich) and the second
digestion plated in tissue culture flasks using a-MEM supplement-
ed with antibiotics (100 g/ml penicillin G, Sigma-Aldrich; 50 g/
ml gentamicin, Sigma-Aldrich; 3 mg/ml amphotericin B, Gibco,
Grand Island, NY, USA and 15% fetal bovine serum (Cansera,
Rexdale, Ont., CAN). Osteoblasts were removed from the tissue
culture plastic using a trypsin solution [0.25% trypsin (Gibco),
0.1% glucose, citrate-saline buffer (pH 7.8)]. MC3T3-E1 pre-
osteoblasts (Sigma-Aldrich, Canada), ROS-17/2.8 cells and
MG63 osteoblast-like cells were purchased as cell lines from
ATCC, Rockville, MD, USA. All cells were grown in a-MEM
medium supplemented with antibiotics (100 g/ml penicillin G;
50 g/ml gentamicin; 3 mg/ml amphotericin B, Gibco) and 15%
fetal bovine serum (Cansera). Cells were removed from the tissue
culture plastic using a trypsin solution [0.25% trypsin (Gibco),
0.1% glucose, citrate-saline buffer (pH 7.8)]. The maturation of
each cell type was confirmed via real-time PCR as described in
figure S1. Cells were seeded at a density of 10,000 cells per 24 well
culture plate (Falcon) for cell proliferation experiments and 50,000
cells per well for real-time PCR and alizarin red experiments
cultured in a-MEM medium supplemented with antibiotics and
15% FBS.
Proliferation Assay
Cell proliferation was quantified using the CellTiter 96 One
Solution Cell Assay (MTS) (Promega, Madison, WI, USA) as
previously described [43]. Cells were seeded in 24-well plates at a
density of 10,000 cells per well in 24 well culture plate. After 3 and
5 days, cells were washed with PBS and then incubated with 80 mL
of CellTiter96 aqueous solution dissolved in 400 mL of PBS. After
4 h of incubation, cell viability was determined by measuring the
absorbance at 490 nm on a 96-well plate-reader. Experiments
were performed in triplicate with three independent experiments
for each condition. Data (+/2 SE) were normalized to control
cells not seeded with EMD at 1 day for each cell type. Data were
analyzed for statistical significance using 2-way analysis of variance
(ANOVA) with Bonferroni test (*, p,0.05).
Real Time RT-PCR
Total RNA was isolated from cells using TRIZOL reagent and
RNAeasy Mini kit (QIAGEN) at time point 14 days for osteoblast
differentiation analysis. Primer and probe sequences for genes
encoding collagen 1a1 (COL1, Hs01028970_m1), alkaline phos-
phatase (ALP, Hs01029144_m1), osteocalcin (OC, also known as
bone gamma-carboxyglutamic acid-containing protein (BGLAP),
Hs01587814_g1) and Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH, Hs03929097_g1) were purchased as pre-designed gene
expression assays (Applied Biosystems). Real-time RT-PCR was
performed using 20 ml final reaction volume of TaqManH’s One
step Master Mix kit. RNA quantification was performed using a
Nanodrop 2000c and 100 ng of total RNA was used per sample
well. All samples were assayed in triplicate and 3 independent
experiments were performed. The DDCt method was used to
calculate gene expression levels normalized to GAPDH values and
normalized to control samples at 1 day. Data were analyzed for
statistical significance using 2-way analysis of variance (ANOVA)
with Bonferroni test (*, p,0.05).
Alizarin Red Quantification
Alizarin red staining was performed to determine the presence
of extracellular matrix mineralization after 21 days of cell culture.
Cells were seeded at a density of 50,000 cells per well in 24 well
culture plates onto control and EMD-coated tissue culture plastic.
After 21 days, cells were fixed in 96% ethanol for 15 minutes and
stained with 0.2% alizarin red solution in water (pH 6.4) at room
temperature for 1 hour. Alizarin red was dissolved using a solution
of 20% methanol and 10% acetic acid in water for 15 minutes.
Liquid was then transferred to cuvettes and optical density was
read on a spectrophotometer at a wavelength of 450 nm. Three
independent experiments were performed each with 3 replicates
for each condition. Data was analyzed for statistical significance
using one-way analysis of variance with Tukey’s test (*, p,0.05).
PDL Cell Passaging Experiment
PDL cells were grown to confluency and then passaged using
trypsin solution (Invitrogen). At cell passage 2, 5, 10 and 15 cells
were trypsinized and seeded at a density of 10,000 cells per well in
24 well culture plates (Falcon) for cell proliferation experiments
Influence of EMD on Cell Maturation
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and 50,000 cells per well for real-time PCR experiments with or
without EMD as previously described. Three independent
experiments were performed each with 3 replicates for each
condition. Data were analyzed for statistical significance using 2-
way analysis of variance (ANOVA) with Bonferroni test (*,
p,0.05).
MC3T3-E1 Cell Differentiation Experiment
The mice pre-osteoblast cell line MC3T3-E1 was used to
determine the influence of cell differentiation down the osteoblast
lineage. Due to the ability for this cell-line to undergo spontaneous
osteoblast differentiation induced by cell-cell contacts once
confluency is reached under standard in vitro conditions [44,45].
These cells were left in T-75 flasks for 0, 7, 14 and 28 days to
determine the effect EMD might have following their gradual
differentiation. At desired time points, cells were trypsinized and
seeded at a density of 10,000 cells per well in 24 well culture plates
(Falcon) for cell proliferation experiments and 50,000 cells per well
for real-time PCR experiments with or without EMD as previously
described. Three independent experiments were performed each
with 3 replicates for each condition. Data were analyzed for
statistical significance using 2-way analysis of variance (ANOVA)
with Bonferroni test (*, p,0.05).
Results
Effect of EMD on Various Osteoblast-derived Cell Lines
The impact of EMD was first tested on the proliferative capacity
of various cell types (Fig. 1). At 3 days post seeding (Fig. 1A), EMD
showed a significant effect on 4 of the 6 cell types. The 2 osteoblast
derived cell-lines MG63 and ROS cells demonstrated a non-
significant increase in cell proliferation. By 5 days post seeding
(Fig. 1B), EMD significantly upregulated all cell types irrespective
of their species origin and differentiation state. Little differences
were observed with respect to their proliferative potential.
Following cell proliferation, each cell type was exposed to EMD
and evaluated for osteoblast differentiation by assessing mRNA
levels of genes encoding COL1, ALP and OC (Fig. 2). EMD
significantly increased COL1 expression, however a larger increase
was observed in MC3T3-E1 pre osteoblast cell-line compared to
the other cell types (Fig. 2A). Similarly, EMD significantly
increased mRNA levels of ALP in all cell types. However, here a
slight increase in ALP mRNA levels was observed for cells of an
earlier lineage including MC3T3-E1 cells, primary RCOs and
human PDL cells when compared to mature osteoblasts (Fig. 2B).
This effect was further supported by OC mRNA data where almost
a 4 fold increase was observed for MC3T3-E1 cells treated with
EMD compared to its control whereas less than a 2 fold increase
was observed in mature osteoblast cell lines including ROS and
MG63 cells and primary HAO (Fig. 2C). Figure 3 demonstrates
alizarin red (AR) staining for all groups treated with EMD
following 21 days incubation. Control cells earlier in their
differentiation stages (MC3T3-E1 cell-line and RCO) showed
lower levels of AR staining when compared to osteoblasts of a
more differentiated phenotype (Fig. 3). Although the effects of
EMD were more pronounced in cells earlier in their differentiation
stages (MC3T3-E1 cell-line and RCO), the mineralization as
demonstrated via AR staining seamed to reach a plateau for all cell
types (Fig. 3).
Effect of PDL Cell Passaging on Responsiveness to EMD
Treatment
In order to determine the effects of over-passaging primary cells
in response to treatment with EMD, primary human PDL cells
were exposed to EMD treatment following cell passages 2, 5, 10
and 15 (Fig. 4, 5). PDL cells passaged 2 and 5 times revealed a
significant increase in cell proliferation at 3 and 5 days post
seeding in response to EMD (Fig. 4A, B). Cells that were passaged
10 and 15 times were no longer able to respond to treatment with
EMD. A similar effect was also observed on mRNA levels of genes
encoding COL1, ALP and OC (Fig. 5). EMD significantly
upregulated all osteoblast differentiation markers for cells passaged
2 and 5 times, however when cells were passaged 10 or more
times, PDL cells were no longer able to respond to treatment with
EMD (Fig. 5). Furthermore, in control samples not coated with
EMD, expression of ALP and OC had both been decreased by 2
fold when compared to control samples at passages 2 demonstrat-
ing not only a negative response to treatment with EMD but also a
loss of function and responsiveness to regular cell culture
conditions.
Effect of EMD on MC3T3-E1 Pre-osteoblasts at Various
Differentiation Stages
This experiment sought to determine the effect of EMD on a
pre-osteoblast cell line and to monitor its response as cells were
gradually differentiated down an osteoblast phenotype (Fig. 6 and
7). MC3T3-E1 mice pre-osteoblast cell line were gradually
differentiated towards the osteoblast phenotype via spontaneous
differentiation induced by cell-cell contacts once confluency was
Figure 1. EMD significantly increases cell proliferation at (A) 3
and (B) 5 days post seeding for cell types including MC3T3-E1
pre-osteoblasts, primary rat calvarial osteoblasts (RCOs),
primary human PDL cells, ROS osteoblast cell line, MG63
osteoblast cell line, and primary human alveolar osteoblasts
(HAO).
doi:10.1371/journal.pone.0071008.g001
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reached under standard in vitro tissue culture conditions for a
period ranging from 0 to 28 days (Figure S2). The effects of EMD
on the proliferation potential of MC3T3 cells was not significantly
altered for cells under standard tissue culture conditions from 0 to
28 days at either 3 or 5 days post seeding (Fig. 6). EMD was able to
significantly increase cell proliferation at all time points irrespec-
tive of the number of days cells remained in confluency prior to
EMD treatment. The effect of EMD on MC3T3 cells was then
tested for cell differentiation by assessing mRNA levels of COL1,
ALP and OC (Fig. 7). In this experiment, a time dependant effect
Figure 2. Effects of EMD on mRNA levels of osteoblast
differentiation markers including (A) collagen1 (COL1), (B)
alkaline phosphatise (ALP) and (C) osteocalcin (OC) as assessed
by real-time PCR at 14 days post seeding. EMD significantly
increased COL1, ALP and OC for all cell types with large variability. EMD
increased mRNA levels of osteoblast markers more prominently in cell
types early in their differentiation process (MC3T3 pre-osteoblasts and
PDL cells) when compared to mature osteoblasts (ROS and MG63
osteoblast cell lines, HAO).
doi:10.1371/journal.pone.0071008.g002
Figure 3. Alizarin red staining (ARS) of various cell types
receiving treatment with EMD. A significant increase in ARS staining
was observed in all cell types treated with EMD.
doi:10.1371/journal.pone.0071008.g003
Figure 4. Effect of EMD on primary human PDL cells passaged
2, 5, 10 and 15 times on cell proliferation at (A) 3 and (B) 5 days
post seeding. EMD significantly increased cell proliferation of cells
passaged up to passage 5. For cell passage 10 and 15, a significant
increase in cell proliferation was no longer observed at either 3 or 5
days post seeding.
doi:10.1371/journal.pone.0071008.g004
Influence of EMD on Cell Maturation
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was observed for MC3T3 cells having been left in confluency from
0 to 28 days. A significant decrease in the cells ability to produce
ALP and OC was significantly reduced following 28 days in
standard culture medium without passage prior to treatment with
EMD (Fig. 7).
Discussion
EMD is a widely used biologic agent capable of enhancing
periodontal wound healing/regeneration [4]. In a systematic
review on the effects of enamel matrix proteins, it was
demonstrated that EMD has a significant influence on cell
adhesion, cell proliferation and cell differentiation of many cell
types by mediating cell attachment, spreading, proliferation and
survival as well as expression of transcription factors, growth
factors, cytokines, extracellular matrix constituents and other
molecules involved in the regulation of bone remodelling [46].
One of the aims of the present study was to investigate the effect
of cell maturation on the response to treatment with EMD. To
achieve this goal, 6 osteoblast cell types, progenitor cells and cell-
lines were utilized ranging from MC3T3-E1 mice pre-osteoblast
progenitor cells, to differentiated osteoblast cell lines including
ROS and MG63 cells. In the present study, we have demonstrated
that EMD was able to significantly upregulate proliferation of all
cell types at 5 days post seeding (Fig. 1). Although little difference
between cell types was observed in cell proliferation rates following
treatment with EMD, the effects of EMD on osteoblast
differentiation was significantly altered. mRNA levels of OC, a
late marker for osteoblast differentiation, was significantly
increased almost 4 fold in MC3T3 pre-osteoblasts, whereas the
effects of EMD on mRNA expression of OC on fully matured
osteoblasts increased less then 2 fold in ROS, MG63 and HAO
(Fig. 2C).
The finding that EMD increased MC3T3-E1 cells is consistent
with findings from other studies in the literature [40,47–50]. To
date, a total of 5 studies have tested the effect of EMD on either
cell proliferation or differentiation of MC3T3-E1 pre-osteoblasts
[40,47–50]. In each of these studies, EMD significantly increased
cell proliferation and markers for osteoblast differentiation [40,47–
50]. Weishaupt et al. demonstrated that the mRNA expression of
Figure 5. Effect of EMD on primary human PDL cell mRNA
expression of genes encoding (A) COL1, (B) ALP and (C) OC. EMD
significantly increased all osteoblast differentiation markers at passages
2 and 5, however failed to increase markers COL1, ALP or OC at passages
10 and 15 days.
doi:10.1371/journal.pone.0071008.g005
Figure 6. MC3T3-E1 pre-osteoblasts were left in T-75 flasks for
0, 7, 14 or 28 days to induce osteoblast differentiation via cell-
cell contacts prior to cell seeding. EMD was able to increase cell
proliferation significantly at both (A) 3 and (B) 5 days post seeding.
doi:10.1371/journal.pone.0071008.g006
Influence of EMD on Cell Maturation
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bone sialoprotein (BSP), also a late marker for osteoblast
differentiation, was upregulated 13.9 times in comparison to
control samples after 16 days of culture when exposed to EMD
[50]. Although BSP was not tested in this study, the result that
EMD was most able to promote osteoblast differentiation of
MC3T3 cells was also shown. Interestingly, in the present study it
was observed that EMD also had a pronounced effect on PDL cell
differentiation down the osteoblast lineage. In a number of
previous in vitro experiments from our laboratory determining the
effects of EMD in combination with various bone grafting
materials [51–54], it was consistently found that human PDL cell
responded more preferably to EMD when compared to osteoblasts
treated with EMD in the same in vitro conditions [51,53]. In light
of these results and with the combination of the current
experiments, an accumulation of evidence provides more support
to the fact that EMPs target cells earlier in their differentiation
process.
The second aim of this study was to determine the effect of
EMD on primary human PDL cells having been passaged 2, 5, 10
or 15 times. To the best of our knowledge, to date no study has
compared the influence of cell passaging of primary human cells in
response to treatment with EMD. In the present study it was
observed that cells passaged 2 and 5 times responded favourably to
treatment with EMD but PDL cells passaged 10 and 15 times were
no longer able to proliferate or differentiate in response to EMD
(Fig. 4, 5). The results from the present study thus showed that
primary cells having been passaged more then 5 times may lose
their inherent properties to differentiate and proliferate in response
to EMD and potentially other growth factors. While a large
number of studies have tested the response of EMD to primary
human cells, a number of them have failed to report up to which
passage number these cells are utilized. The results from the
present study suggest that this information may have major
implications on in vitro cell response.
In the third set of studies, MC3T3-E1 cells were utilized because
of their undifferentiated phenotype as well as their ability to
respond to EMD both in previous studies and also in this study. It
has previously been reported that cells having undergone cell-cell
contacts are able to gradually differentiate down the osteoblastic
lineage [44,45]. Because in vitro cell maintenance conditions are
rarely reported in the literature, this method of induction down the
osteoblast lineage was chosen as opposed to inducing osteoblast
differentiation via differentiation factors including ascorbic acid,
beta-glycerophosphate and/or dexamethasone [55,56] to demon-
strate the ability of cells to lose their potential to respond to
treatment from EMD. In this study, a time-dependant reduction in
osteoblast differentiation was observed when cells were left
unpassaged from 7 to 28 days following treatment with EMD.
Interestingly, we have previously reported that EMD enhances
osteoblast differentiation via cell-cell contacts by upregulating
osteoblast gap junctional proteins, connexin 43 (cx43) [32]. Gap
junctions are aqueous transmembrane channels that connect the
cytoplasm of two adjacent cells and allow the diffusion of small
molecules with a molecular mass of less than 1 kDa such as small
metabolites, ions, and intracellular signaling molecules (calcium,
cAMP, and inositol triphosphate) to pass through [57]. Cx43
molecules are absolutely essential for osteoblast differentiation and
function [58–61] and EMD targets their upregulation [32]. The
results from the present study may also indicate that cx43 may be
implicated in the down-regulation of osteoblast differentiation in
response to EMD following cell maturation. However, this
hypothesis requires further experimental investigations.
Conclusions
The results from the present study suggest that EMD has a more
pronounced effect on cells earlier in their differentiation process.
The effects on mRNA levels of osteocalcin were most prominent
on MC3T3-E1 pre-osteoblasts, primary RCOs and PDL cells and
gradually decreased to a more mature osteoblast phenotype.
Furthermore, primary human PDL cells passaged 10 or more
times were no longer able to respond to treatment with EMD and
the same observation was observed for MC3T3 pre-osteoblasts
that had undergone osteoblast differentiation via cell-cell contacts.
The results from the present study may also provide support for
the clinical and histological observations that EMD seems to
favour regeneration of periodontal tissues including the periodon-
Figure 7. mRNA levels of (A) COL1, (B) ALP and (C) OC of MC3T3-
E1 pre-osteoblasts that were left in T-75 flasks for 0, 7, 14 or 28
days to induce osteoblast differentiation via cell-cell contacts
prior to cell seeding. EMD significantly increased cell differentiation
for all osteoblast markers up to 14 days. At 28 days, only COL1 was
significantly up-regulated. The effects of EMD on MC3T3 pre-
osteoblasts decreased as cells were left in flasks from 0 to 28 days.
doi:10.1371/journal.pone.0071008.g007
Influence of EMD on Cell Maturation
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tal ligament which contains a high proportion of undifferentiated
progenitor cells when compared to pure alveolar bone defects.
Supporting Information
Figure S1 MC3T3 cells, primary RCO, PDL cells, ROS
cells, MG63 cells and primary HAO were analyzed for
mRNA expression of osteoblast differentiation markers
A) COL1, B) ALP, and C) OC at baseline prior to all
experiments to confirm their maturation state. A)
Although no significant difference was observed for COL1
expression, cell-lines ROS and MG63 as well as primary HAO
demonstrated higher levels at baseline for genes encoding COL1
as assessed by real-time PCR. B) A significant increase in genes
encoding ALP and OC were observed in cell-lines ROS and
MG63 as well as HAO at baseline when compared to MC3T3
pre-osteoblasts, primary RCO and human primary PDL cells. The
results from the present experiment demonstrates higher expres-
sion of osteoblast-related differentiation markers in human
primary osteoblasts and osteosarcoma-derived cell lines when
compared to pre-cursor cells derived from a mesenchymal origin
(MC3T3 cells), neonatal rat calvaria and PDL cells. (*, p,0.05,
results from 3 independent experiments).
(TIF)
Figure S2 MC3T3 cells were left in T-75 flasks for 0, 7,
14 and 28 days to gradually differentiate cells towards
the osteoblast lineage via spontaneous differentiation
induced by cell-cell contacts once confluency was
reached under standard in vitro conditions. At time points
0, 7, 14 and 28 days, cells were analyzed for mRNA expression of
osteoblast differentiation markers A) COL1, B) ALP, and C) OC
prior to application with EMD to confirm the differentiation of
pre-osteoblasts down the osteoblast lineage. A non-significant
increase in mRNA levels of COL1 and ALP was observed from 0
to 28 days demonstrating the gradual increased expression of
osteoblast-related markers in the absence of osteoblast differenti-
ation media. A significant increase in OC, a late marker for
osteoblast differentiation, was observed 14 days post-confluency,
and a 3.5 fold significant increase was observed. (*, p,0.05, **,
p,0.05 above all other values, results from 3 independent
experiments).
(TIF)
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